Delivery Order SPE2DR25D2206-SPE2DR26F9FD4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,540.52 to AmerisourceBergen Drug Corp on December 1, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $1,599.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award was made on a competitive, non-set-aside basis to the major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,062.47 to AmerisourceBergen Drug Corp on October 20, 2025, with an ultimate completion date of October 21, 2025. This contract is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which is also the headquarters of the prime contractor. This delivery order represents a child contract under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,234.63 to AmerisourceBergen Drug Corp on October 28, 2025, with an ultimate completion date of October 29, 2025. This firm fixed-price delivery order, issued under a non-set-aside competitive procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is...
- The Defense Logistics Agency awarded a $105,989.02 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The contract is performance-based at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $47,026.31 delivery order to AmerisourceBergen Drug Corp on December 6, 2025, for pharmaceutical products and medical supplies to support federal healthcare needs. This firm fixed-price, competitively awarded contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $44,033.86 to AmerisourceBergen Drug Corp on December 2, 2025, for pharmaceutical products under the Pharmaceutical PV Division. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 3, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child award under a larger indefinite delivery contract vehicle with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,666.41 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. The contract, which is a child order under a larger indefinite delivery vehicle, was awarded on December 1, 2025, with a completion date of December 2, 2025, using firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded...
- The Defense Logistics Agency awarded a delivery order valued at $7,441.47 to AmerisourceBergen Drug Corp on December 4, 2025, for pharmaceutical and medical supply products under the contract designation 4570169744. This firm fixed price delivery order, with an ultimate completion date of December 5, 2025, represents a child contract issued against AmerisourceBergen's larger indefinite delivery vehicle and is structured as a non-competitive set-aside award. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,822.30 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies on December 10, 2025, with completion expected by December 11, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FD4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,332.00 to AmerisourceBergen Drug Corp on December 10, 2025, with an ultimate completion date of December 11, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under DLA's pharmaceutical supply chain operations. The contract calls for delivery of medical supplies to the Conshohocken, Pennsylvania location, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. This delivery order functions as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical commodities to support military healthcare programs worldwide. The parent contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard through a flexible procurement mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/9/25 |